Category Archives: Cannabis Legalization

How to Select a Plant Nutrition Partner for Your Cannabis Business

By Eric Sandy

How to Select a Plant Nutrition Partner for Your Cannabis Business

The cannabis market is awash in plant nutrition options. Growers of all experience levels may easily feel daunted by the sheer scope of nutrient program offerings. The range of data points needed to be adequately informed on plant nutrition is also deep; cannabis growers can’t go into this process without knowing precisely what they’re looking to get out of their crops.

With decades experience behind Harrell’s entrance into the cannabis space, the company’s MAX Rx program is set up in a way to fit any grower’s needs. Customization and compatibility are key—not only to what Harrell’s is offering the cannabis industry, but to all growers’ approaches to providing high-quality nutrients to their plants.

It’s vital to understand your own business and the background of any prospective plant nutrition partners, according to Harrell’s Director of Agronomy Jeff Atkinson.

The company was founded in 1941 in Lakeland, Fla. The goal has always been to deliver customized agronomic solutions for a spectrum of plant needs. As cannabis becomes the increasingly competitive marketplace we see today in the U.S., that custom-built product line-up is the sort of thing that will complete cannabis cultivation facilities of all sizes.

Here, Atkins lays out three fundamentals to working through that process and selecting a trustworthy partner. “For us, reputation is everything,” he says.

Cost and Value

“There are a lot of different sources for nutrients out there,” Atkinson says. “We’re able to provide a concentrated, quality product at a cost they likely won’t find.”

Of course, when selecting any vendor for your business, cost is king. Plant nutrition programs should be built into your business to increase yield and  profits; if the cost is cutting into your bottom line, then you’re off to a bad start.

“The business is just going to get more competitive,” he says. “There are going to be more constraints on cost and overhead that go into producing these crops. Growers need to understand how much they are really spending on any number of things—lighting, facilities, fertility, … pest control. Once they have that information, they can take a look and say, ‘What are my fertility options? Where can I control my costs and where can I get a consistent product?’”

Before getting into the work of selecting a plant nutrition partner, growers should take a close look at precisely where their own business strengths and weaknesses lie—where to fit a solid program into the balance sheets.

“We look at it as an investment,” Atkinson says. “You get what you pay for.”


This is one of the tentpole mandates that drove Harrell’s to develop the MAX Rx line. Cannabis growers may be coming to the company from all sort of avenues in the industry; Harrell’s, in turn, insists that a plant nutrition partner must provide solutions that are compatible across all types of cultivation. Atkinson says that the company set out to create a line of products for cannabis growers, and that each must be clean, clear and compatible.

Look for the track record of a business.

“By using high-quality ingredients, you know that you’re going to have compatibility between products,” Atkinson says. “You know that they’re going to provide a plant response that you’re looking for—and you know that you’re going to get a good value for the money that you’re investing.”

“All of that [is] so that we have confidence as a company in our products—but, as an extension of that, our customers have confidence in our products, that they’ll do what they say they’ll do, that the customer is getting what we’re telling them they’re buying,” Atkinson says.

To read more..

This oil made from hemp plants is taking the world by storm

By  Business

Long gone are the days when people were scared of the consequences of cannabis. With the overwhelming growth of the popularity of these green leaves, it is not surprising that more and more researchers are working to establish the efficacy of the CBD products on our health.

While the pros do seem to outweigh the cons as of now, it is also very important to ensure that you don’t necessarily end up consuming it in a dosage that would end up doing you bad than good.

In here, we are going to be discussing the rising popularity of these cannabis rich products and why they are beneficial altogether.

Relieves pain

The very first fact about the CBD infused products is the fact that it has amazing benefits in relieving the condition of pain altogether. Several studies have shown that the CBD (cannabidiol) does have the potency to impart beneficial analgesic properties on the body by impacting the endocannabinoid system in the body. The process involved in this is still in the pre-clinical stage of researchers which is why it is beneficial to be cautious of what you are opting for and how much to relieve the signs and symptoms associated with pain.

Amazing for anxiety and depression

Mental health issues are on the constant rise around the globe. With the lack of awareness surrounding it, it is not surprising that the numbers are multiplying with each passing year. CBD has been found to have beneficial impacts in handling the conditions associated with anxiety and depression. CBD oil is believed to be the best potent remedy for handling these conditions. While there are still a number of ongoing researches concerning the same, it is believed that it does help in calming down the overexcited nervous system, thus handling the symptoms effectively.

Prevent cancer risks

Yet another one of the amazing impacts and benefits of CBD is the fact that it helps in keeping the risks of cancer at bay. Studies have found that the administration of this has been quite helpful in handling the symptoms related to cancer and even the side effects that do come along with this treatment process for those who are already suffering. Although the current researches do suggest a positive outlook, more research needs to be done to establish a concrete answer to this.

To read more…

Cannabis Thought Leader: ‘It’s Inevitable’ Big Pot Will Stifle Small Business

By Chloe Aiello

As more companies test the waters of the legal hemp and cannabis industries, “it is only inevitable” behemoths in alcohol, tobacco, and consumer goods will start to dominate market share, said Ricardo Baca, cannabis thought leader and founder of public relations firm Grasslands.

“In the same way that we have a strong microbrew market in the beer market, and boutique hotels compared to the big dogs, there will also be the best-of-the-best small cannabis and hemp brands,” said Baca, who also served as editor of The Denver Post’s The Cannabist. “But … these brands that have capital, have reach, they are going to take over market share. We are already seeing it in the U.S. and we are certainly seeing it in Canada.”

His comments came on the heels of news that CVS will start selling CBD products in hundreds of its stores nationwide as part of a deal with Curaleaf Holdings. CVS isn’t the first mainstream brand to embrace the burgeoning hemp and cannabis markets. DSW and Simon Malls now sell CBD products through deals with Green Growth Brands. And Corona-beer maker Constellation Brands ($STZ) and tobacco giant Altria ($MO), which owns Marlboro, have both made significant investments in Canadian cannabis companies.

To read more…

CBD: The New Popular Business and Wellness Trend of 2019?


One by one, varying states are legalizing marijuana to treat a variety of medical conditions, and some states are even legalizing it for recreational use. The cannabis industry is in its very beginnings. Still, there are exciting developments emerging in the field, and despite the marketplace’s freshman status, manufacturing and retail stakeholders are already developing a knack for creating and marketing cannabis products in ways that appeal to mainstream consumers.

The Nuts and Bolts of Cannabis

According to Chad Conner, professor at the Pacific College of Oriental Medicine, one reason that cannabindiol (CBD) products are creating such a stir is that they can affect positive health outcomes among a range of human physiological systems. A recent interview with the professor reveals that CBD is one of more than 100 cannabinoids that work with the human endocannabinoid neurotransmitter system.

For this reason, physicians have been able to successfully treat many conditions. They’ve found success in using CBDs to treat several illnesses, including:

  • Neurological problems
  • Anxiety
  • Autoimmune problems
  • Eczema
  • Immune regulation
  • Inflammation
  • Pain
  • Psoriasis
  • Sleep deprivation

Conner states that the amount of THC in a CBD product is what differentiates various strains of the compound. In other words, the THC content establishes the status of each strain.

Conner reassures that CBD hemp is a safe compound. With the exception of THC, all cannabinoids are non-intoxicating. Even at high doses, CBD is safe, although users may exhibit some minor side effects.

To read more…




To read more …

The Growing Business of CBD, the Non-Addictive Cannabis Compound


Cannabidiol, commonly referred to as CBD, is a naturally occurring chemical compound called a cannabinoid found in cannabis. Unlike THC, there are no psychoactive effects from ingesting CBD, and the World Health Organization determined it “exhibits no effects indicative of any abuse or dependence potential.” The sector of the burgeoning marijuana industry dedicated to CBD — often sold in the form of hemp extract oil — touts its myriad benefits for multiple maladies. However, the only FDA-approved CBD product is Epidiolex, which is used to treat a rare seizure disorder in children.

“The other CBD products currently being sold are not FDA approved and generally unregulated,” says Dr. Deepak D’Souza, staff psychiatrist at the VA Connecticut Healthcare System and professor of psychiatry at the Yale University School of Medicine. “These products are highly variable in their CBD content and it is therefore difficult to draw conclusions about their purported beneficial effects.”

The WHO’s Expert Committee on Drug Dependence acknowledged “preliminary evidence that CBD may be a useful treatment for a number of other medical conditions” besides seizures. The committee also found “no evidence of recreational use of CBD or any public health related problems associated with the use of pure CBD.”

To read more…

“Hemp prohibition is over!” & more CBD Takeaways from Expo West

Anaheim, CA—CBD, cannabidiol, hemp, phytocannabinoids, endocannabinoids, full-spectrum extract, CBD isolate—as WholeFoods previously reported, the debate over which forms to put into products, how to label it, what to say about it (and what not to say) at the retail level grows larger and louder as hemp-based products gain popularity, which seems to be happening at record speed. Just months after the passage of the Farm Bill, CBD is showing up in a wide range of products and retail outlets; the latest, just in time for Easter: Jelly Belly creator David Klein has a new line of CBD-infused jelly beans, according to a report in USA Today. And at Expo, of the 3,600 exhibiting companies, 120 classified themselves as having CBD ingredients on the official Expo website, while 117 listed all forms of hemp (although there is crossover there).

The CBD market is expected to rake in $16 Billion by 2025, according to a Forbes report on a survey by investment bank Cowen & Co. With estimations like that, it’s no wonder pretty much everyone was clamoring to gain a better understanding of the CBD landscape at Expo West. Here, need-to-know information:

“Hemp prohibition is over!” That statement came from Jonathan Miller, general counsel of the U.S. Hemp Roundtable and former Kentucky State Treasurer, speaking at a panel titled Legalized it! Or did we? at the Natural Products Hemp & CBD Summit. His words were met with cheers and applause. That said, it was acknowledged that there is still work to be done. “We now have clear bipartisan support in Congress. There is still a way to go, but we will get there.” He noted that there are resources to help get messages to those in Congress at

Federal vs. State Regulations: Rend Al-Mondhiry of Amin Talati Upadhye helped clarify where things stand: The Farm Bill did legalize at the federal level, but states can have more stringent regulations—and many do. “Even trace amounts of THC,” she said, “could cause a product to be a controlled substance in those states.”

An overview of the “patchwork of state regulations” as presented by Al-Mondhiry:

  • ID, SD and NE consider CBD, including hemp-based CBD, to be illegal under state law
  • CA, ME, NC and TX have adopted the FDA position that hemp-based CBD can’t be a dietary supplement or food ingredient
  • OK, TN and other states allow CBD use only for certain medical conditions
  • NY required hemp-based CBD to be labeled and manufactured as a dietary supplement.
  • WY and KS have a 0% THC requirement
  • IN, UT and OR have labeling and packaging requirements (such as QR codes) that must be considered

To read more…

NJ legal weed: What’s next for bill to legalize marijuana

By , Trenton Bureau

Monday could be the day when the Legislature takes a historic vote to legalize marijuana for adult recreational use in New Jersey.

Or it could be the day when Democratic leaders concede defeat in convincing enough colleagues to get on board, setting the legalization effort back months and raising doubts about the fate of one of Gov. Phil Murphy’s central campaign promises.

Here’s what is next with the landmark bill:

Key test Monday

After successful, if controversial, votes by legislative committees earlier this week, the full Senate and Assembly are scheduled to vote on the legalization bill Monday.

The sweeping, 175-page bill would allow possession of small amounts of cannabis by adults over 21 and clear the records of those with marijuana-related convictions. It also would lay the framework for regulating and taxing a new billion-dollar industry.

But with Republicans largely unified against the measure and several rank-and-file Democrats opposed or wavering, it appears just as likely that legislative leaders scrap the vote for lack of support.

Lobbying effort underway

Which way it goes depends on how successful Murphy, Senate President Stephen Sweeney and Assembly Speaker Craig Coughlin, all Democrats, are in enticing lawmakers to cast a “yes” vote.

They have plenty of inducements at their disposal, from appointments to money for lawmakers’ districts. But many legislators have firm beliefs on the topic of marijuana and may be difficult to sway.

To read more…

Three things to know about Pa.’s latest legal cannabis proposal


Pennsylvanians over the age of 21 would be able to legally use recreational cannabis under a bill expected to be introduced soon in the Pennsylvania state Senate.

But the bill has a long way to go — and a lot of Republican opposition to overcome — before it can land on Gov. Tom Wolf’s desk.

Senators Daylin Leach, D-Montgomery, and Sen. Sharif Street, D-Philadelphia, announced the bill Monday in a memo to their colleagues, where they said that legalizing recreational cannabis would remedy the injustices of the War on Drugs and generate revenue for Pennsylvania’s communities and public schools.

“Cannabis is still widely available to purchase illegally, and yet we disproportionately arrest, prosecute, monitor, and incarcerate thousands of nonviolent Pennsylvanians who are poor and people of color,” the memo reads. “Cannabis prohibition is an immoral and expensive failure of public policy.”

They’ve introduced similar bills in the past with no luck. This time around, though, they’re operating in a different climate.

Wolf said last year that it was time for Pennsylvania to take a “serious look” at legalizing marijuana. The same month, public polls showed that 59 percent of Pennsylvanians support legalization — up from 22 percent in 2006.

Lt. Gov John Fetterman is currently conducting a statewide listening tour, where he’s stopping in all of Pennsylvania’s 67 counties to hear people sound off on the issue. And there’s a legalization effort underway in the House, thanks to a bill introduced by Rep. Jake Wheatly, D-Allegheny.

Street said on Monday that the lawmakers made social justice, inclusion, and economic development their priorities in crafting the new bill. Here are three things to know about it.

To read more…